Clinical trial · Observational
Fertility Protection for Children, Adolescents and Young Adults
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study focuses on improving fertility preservation and long-term care for children, adolescents, and young adults (CAYA) undergoing cancer treatments or stem cell transplantation. These treatments can harm fertility, and ensuring that patients receive the right support and follow-up care is critical. The main study goals are: 1. Understanding Fertility Risks: Researchers aim to identify factors that predict fertility problems after cancer treatments, such as the type of therapy, hormone levels, body composition, or genetic predispositions. 2. Addressing Patient and Family Needs: The program will explore the concerns, needs, and challenges faced by young patients and their parents regarding fertility. It will also examine how these issues affect their quality of life. 3. Improving Clinical Care: Current practices in fertility preservation and counseling will be studied to identify gaps and improve care structures. To achieve these goals, the program will: * Create a database to collect and analyze medical data from patients before, during, and after cancer treatments. * Study the prevalence and long-term effects of fertility problems in young patients. * Document medical interventions like fertility preservation methods (e.g., freezing eggs or sperm) and treatments for late effects. * Assess patients' and families' fertility-related quality of life and their informational needs. Ultimately, the project aims to establish an interdisciplinary center to support fertility preservation and improve the quality of care for young patients facing cancer and its treatments.
Conditions
Conditions (11)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| CAYA | — | UNRESOLVED | — |
| Endocrinological Late-effects | — | UNRESOLVED | — |
| Fertility | — | UNRESOLVED | — |
| Fertility Protection | — | UNRESOLVED | — |
| Oncological Children | — | UNRESOLVED | — |
| Oncological Outcomes | — | UNRESOLVED | — |
| Oncological Patients | — | UNRESOLVED | — |
| Paediatric Oncology | — | UNRESOLVED | — |
| Stem Cell Transplant | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (4)
- label
- FeProCAYA-Onc
- description
- Children, adolescents, young adults (age \<21 years) with a diagnosis of cancer before the initiation of oncological therapy or prior to SCT (stem cell transplantation) for a malignant or non-malignant disease with prospective follow-up.
- label
- FeProCAYA-Onc (MidTerm)
- description
- Children, adolescents, and young adults with a diagnosis of cancer before the age of 21 years and \>5 years of follow-up after initial cancer diagnosis
- label
- FeProCAYA-Onc (long-term)
- description
- Adults with a diagnosis of cancer before the age of 21 years and \>20 years of follow-up after initial cancer diagnosis
- label
- FeProCAYA-SCT
- description
- Children and adolescents (age \<21 years) with a malignant or non-malignant condition requiring stem cell transplantation (SCT) prior to SCT with prospective follow-up.
Primary outcomes (2)
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Children, adolescents, young adults with a diagnosis of cancer before the age of 21 years or Children, adolescents, young adults undergoing SCT for a malignant or non-malignant condition before the age of 21 years treated at the Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Germany.
References
Publications (0)
Data not yet available